A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)
Condition: Pulmonary Disease, Chronic Obstructive Interventions: Drug: Aclidinium bromide; Drug: Aclidinium bromide/formoterol; Drug: Other COPD medication Sponsors: AstraZeneca; RTI Health Solutions Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials